Global Gene Synthesis Service Market Strategic Research Report

Scope of the Report

The global Gene Synthesis Service market size is predicted to grow from US$ 790 million in 2025 to US$ 2,203 million in 2032; it is expected to grow at a CAGR of 16.0% from 2026 to 2032.

Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.

The Market Driver is the primary propelling the gene synthesis market forward is the rapid advancement of synthetic biology. This interdisciplinary field leverages gene synthesis to engineer biological systems for diverse applications, including bio manufacturing, healthcare, and agriculture. With gene synthesis enabling precise design and construction of custom DNA sequences, synthetic biology stands at the forefront of innovation, driving demand for gene synthesis services and technologies.

Despite its potential for growth, the gene synthesis market faces significant challenges related to quality control and reliability. Ensuring the accuracy and fidelity of synthesized DNA sequences is paramount for research reproducibility and commercial applications. Quality control issues such as sequence errors, synthesis errors, or contamination can undermine confidence in gene synthesis services and impede market expansion. Thus, addressing quality assurance challenges is crucial for sustaining the growth trajectory of the gene synthesis market.

GenScript is the largest supplier of Gene Synthesis, with a revenue market share nearly 26.85% in 2023. That is to say, GenScript is the most popular Gene Synthesis in global, and with most of the Gene Synthesis market share in global. Again, top 5 players dominated 72.41% global gene synthesis market share of the whole market, with most of which were USA companies.

Despite GenScript was ranked #1 in global gene synthesis market, other sophisticated companies in the US and Europe may enter into this sector through M&A on smaller competitors to GenScript or buying related business from other market. This will result in reshuffling of the biomedicine research services’ market, and that GenScript may loss its market share.

Asia-Pacific is the largest consumption market, with a consumption market share nearly 36.39% in 2023. Followed by Asia-Pacific, North America is the second two largest consumption place with the similar consumption market share of 34.45%.

This report presents a comprehensive overview of the global Gene Synthesis Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Below 1000 bp
• 1001 to 3000 bp
• 3001 to 5000 bp
• Above 5000 bp

Segment by players, this report covers

• Genescript
• Thermo Scientific
• IDT
• Eurofins Genomics
• DNA 2.0 (ATUM)
• BBI
• Azenta Life Sciences
• SBS Genetech
• Bio Basic
• Twist Bioscience
• OriGene

Segment by Application

• Commercial
• Academic Research

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Gene Synthesis Service market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Commercial, Academic Research evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact